文献速递泌尿生殖妇产影像MR

结合临床特征的改良O-RADS分类系统对附件病变的诊断效能

Diagnostic performance of a modified O-RADS classification system for adnexal lesions incorporating clinical features.
PubMed 文献 · Abdom Radiol (NY) · 2024-08-20

本研究为双中心回顾性研究,纳入124例含实性组织的附件病变患者(良性40例、恶性84例),比较O-RADS MRI评分与基于简化增强MRI方案的改良O-RADS评分的诊断效能,并评估临床特征的附加价值。改良O-RADS评分特异度更高(75.0% vs 12.5%),AUC更大(0.732 vs 0.575,p<0.001);改良O-RADS 4b或5分联合年龄>38.5岁、未产、最大径>40.5 mm及HE4>78.9 pmol/L可使诊断效能提升至0.954。

要点

  • 改良O-RADS评分AUC 0.732,高于O-RADS MRI评分的0.575(p<0.001)。
  • 改良O-RADS评分特异度75.0%,O-RADS MRI评分仅12.5%。
  • 改良O-RADS 4b或5分联合年龄>38.5岁、未产、最大径>40.5 mm及HE4>78.9 pmol/L,诊断效能达0.954。

核心结论

  • 改良O-RADS评分联合特定临床特征可显著提高预测恶性肿瘤的诊断效能。

研究设计与样本

  • 双中心回顾性研究,纳入124例含实性组织的附件病变患者(良性40例、恶性84例),以组织病理学为参考标准,由3名放射科医师独立评分。

诊断标准与关键数值

  • O-RADS MRI评分敏感度100.0%(95%CI 95.7-100.0%)、特异度12.5%(95%CI 4.2-26.8%)。改良O-RADS评分敏感度71.4%(95%CI 60.5-80.8%)、特异度75.0%(95%CI 58.8-87.3%)。改良O-RADS评分AUC 0.732(95%CI 0.645-0.808),高于O-RADS MRI评分的0.575(95%CI 0.483-0.663),p<0.001。改良O-RADS 4b或5分联合年龄>38.5岁、未产、最大径>40.5 mm及HE4>78.9 pmol/L,诊断效能提升至0.954(95%CI 0.901-0.984),p<0.001。

临床应用与阅片要点

  • 作者认为,改良O-RADS评分联合特定临床特征可显著提高预测恶性肿瘤的诊断效能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the diagnostic efficacy of the Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score with that of the modified O-RADS score on the basis of a simplified contrast-enhanced (CE) MRI protocol in characterizing adnexal masses with solid tissue. The added value of clinical features was evaluated to improve the ability of the scoring system to classify adnexal masses.

METHODS: A total of 124 patients with 124 adnexal lesions containing solid tissue were included in this two-center retrospective study. Among them, there were 40 benign lesions (40/124, 32.3%) and 84 were malignant lesions (84/124, 67.7%). Three radiologists independently reviewed the images and assigned the O-RADS MRI score and the modified O-RADS score for each adnexal mass. Histopathology was used as the reference standard. The diagnostic efficacy of the two scoring methods was compared. Univariate and multivariate logistic regression were performed to evaluate the value of significant features in the prediction of malignant tumors.

RESULTS: The O-RADS MRI score and modified O-RADS score showed sensitivity at 100.0% (95% CI, 95.7-100.0%) and 71.4% (95% CI, 60.5-80.8%), specificity at 12.5% (95% CI, 4.2-26.8%) and 75.0% (95% CI, 58.8-87.3%), respectively. The area under the curve of the modified O-RADS score was higher than the O-RADS score (0.732 [95% CI, 0.645-0.808] vs 0.575 [95% CI, 0.483-0.663]; p < 0.001). Multivariate analysis showed that the modified O-RADS score 4b or 5 combined with patient age > 38.5 years, nullipara, maximum diameter > 40.5 mm and HE4 > 78.9 pmol/L significantly improved the diagnostic efficacy up to 0.954 (95% CI, 0.901-0.984) (p < 0.001).

CONCLUSION: A modified O-RADS score combined with certain clinical features can significantly improve the diagnostic efficacy in predicting malignant tumors.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wu M, Cai S, Zhu L, et al. Diagnostic performance of a modified O-RADS classification system for adnexal lesions incorporating clinical features. Abdom Radiol (NY). 2024. PMID: 39164457. doi:10.1007/s00261-024-04538-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。